Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 161.19B | 187.79B | 140.18B | 147.64B | 130.11B | 99.71B |
Gross Profit | 161.19B | 148.84B | 140.18B | 131.68B | 130.11B | 99.71B |
EBITDA | 50.29B | 58.30B | 46.65B | 24.51B | 39.11B | 27.23B |
Net Income | 36.86B | 35.84B | 27.69B | 12.51B | 22.91B | 21.57B |
Balance Sheet | ||||||
Total Assets | 12.32T | 12.13T | 12.79T | 11.50T | 11.60T | 11.01T |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.73T | 2.84T | 2.19T | 2.58T | 2.58T |
Total Debt | 2.10T | 2.00T | 2.70T | 1.06T | 1.20T | 1.02T |
Total Liabilities | 11.80T | 11.63T | 12.26T | 11.00T | 11.11T | 10.49T |
Stockholders Equity | 524.32B | 504.54B | 535.11B | 498.47B | 496.06B | 516.76B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -18.47B | 661.83B | -478.07B | 208.88B | 1.46T |
Operating Cash Flow | 0.00 | -14.42B | 673.40B | -468.74B | 216.89B | 1.49T |
Investing Cash Flow | 0.00 | -202.52B | -119.39B | 65.83B | -198.33B | -370.40B |
Financing Cash Flow | 0.00 | 57.39B | 94.02B | -8.10B | -22.64B | -9.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥384.07B | 11.65 | 6.13% | 3.72% | 6.67% | 51.21% | |
78 Outperform | ¥345.07B | 11.19 | 5.71% | 3.40% | 4.24% | 23.16% | |
74 Outperform | ¥383.69B | 10.96 | 4.32% | 2.38% | 8.46% | 46.91% | |
71 Outperform | ¥455.38B | 10.18 | ― | 1.48% | 33.00% | 80.88% | |
70 Outperform | ¥426.01B | 11.45 | ― | 3.67% | 14.20% | 29.96% | |
63 Neutral | ¥390.83B | 13.65 | ― | 3.36% | 10.60% | 20.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Hirogin Holdings, Inc. reported a 6% increase in ordinary revenues and a notable 26% rise in ordinary profit for the nine months ended December 31, 2024, compared to the same period the previous year. The company’s financial position remains stable with a slight decrease in total assets and an improved capital adequacy ratio. Despite a decline in comprehensive income, the company has maintained its dividend forecast, signaling confidence in its financial health and ongoing strategic initiatives.